A24.9
Melioidosis, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Infection due to Pseudomonas pseudomallei NOS
- Whitmore's disease
Medical Intelligence & Overview
Melioidosis, also known as Whitmore's disease, is a bacterial infection caused by the organism Pseudomonas pseudomallei. When the specific site or severity of the infection is not identified, it is classified under the ICD-10 code A24.9, indicating an unspecified form of the disease. This condition can affect various parts of the body and can vary from mild to severe, potentially becoming life-threatening if not diagnosed and managed appropriately.
Causes & Symptoms
Clinical Causes: Exposure to contaminated soil or water in endemic regions, particularly during rainy seasons Inhalation or direct contact with bacteria through skin wounds or cuts Contact with infected animals or their environment Recreational activities like swimming or walking in contaminated water bodies Underlying health conditions such as diabetes, chronic kidney disease, or immunosuppressive states that increase susceptibility
Key Symptoms: Fever and chills Localized pain, swelling, or abscesses in affected areas Skin ulcers or nodules Respiratory symptoms like cough, chest pain, or difficulty breathing Weight loss and fatigue Infection spreading to the bloodstream, causing septicemia Various organ-specific signs depending on affected tissues, including liver, spleen, or prostate
Diagnostic & Treatment
Diagnosis Path: Diagnosing melioidosis involves a combination of clinical evaluation and laboratory testing. Physicians typically order blood cultures and tissue cultures to identify Pseudomonas pseudomallei. Imaging studies, such as X-rays or CT scans, may be used to assess organ involvement. Serological tests can support the diagnosis but are less definitive. Due to its diverse presentation, a high degree of clinical suspicion is necessary, especially in patients with risk factors or travel history to endemic areas.
Treatment Protocols: Treatment of melioidosis generally requires a prolonged course of antibiotics. The typical management includes an intensive phase with intravenous antibiotics like ceftazidime or meropenem, followed by an eradication phase with oral antibiotics such as trimethoprim-sulfamethoxazole. Hospitalization may be necessary for severe cases or complications. Supportive care for symptoms and management of complications are also important components of treatment. Early diagnosis and appropriate therapy significantly improve outcomes.
Clinical Advice & FAQs
Billing Guidance
Is A24.9 a billable ICD-10 code?
Yes, A24.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A24.9?
Clinical documentation must specify the nature of Melioidosis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
